Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Klara Kvorning Ternov"'
Autor:
Peter Busch Østergren, Ganesh S. Palapattu, Caroline Kistorp, Jens Sønksen, Ola Bratt, Tobias Wirenfeldt Klausen, Alexander Bjørneboe Nolsøe, Klara Kvorning Ternov, Henriette Lindberg, Mikkel Fode
Publikováno v:
Prostate Cancer and Prostatic Diseases. 24:948-961
Enzalutamide and abiraterone acetate plus prednisone (AAP) have similar efficacy in metastatic castration-resistant prostate cancer (mCRPC), but different mechanisms of action. The aim was to compare patient-reported health-related quality of life (H
Autor:
Frederik M. Jacobsen, Klara Kvorning Ternov, Alexander B. Nolsøe, Peter Busch Østergren, Mikkel Fode, Jens Sønksen, Christian Fuglesang S. Jensen
Publikováno v:
Scandinavian journal of urology. 56(3)
To investigate how urological studies using composite endpoints as the primary outcome were cited.In this quality analysis of citations, three randomized clinical trials each investigating oncological and non-oncological urology were selected for cit
Autor:
Ganesh S. Palapattu, Rasmus Bisbjerg, Peter Busch Østergren, Henriette Lindberg, Mikkel Fode, Jens Sønksen, Klara Kvorning Ternov
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:Baseline serum testosterone has been suggested to be a predictive biomarker of patient important outcomes in men with metastatic castration-resistant prostate cancer (mCR...
Autor:
Klara Kvorning, Ternov, Alexander Bjørneboe, Nolsøe, Ola, Bratt, Mikkel, Fode, Henriette, Lindberg, Caroline, Kistorp, Ganesh, Palapattu, Tobias Wirenfeldt, Klausen, Jens, Sønksen, Peter Busch, Østergren
Publikováno v:
Prostate cancer and prostatic diseases. 24(4)
Enzalutamide and abiraterone acetate plus prednisone (AAP) have similar efficacy in metastatic castration-resistant prostate cancer (mCRPC), but different mechanisms of action. The aim was to compare patient-reported health-related quality of life (H
Autor:
Jens Sønksen, Peter Busch Østergren, Mikkel Fode, Caroline Kistorp, Ganesh S. Palapattu, Klara Kvorning Ternov, H. Lindberg, Rasmus Bisbjerg
Publikováno v:
BMJ Open
Ternov, K K, Sønksen, J, Fode, M, Lindberg, H, Kistorp, C M, Bisbjerg, R, Palapattu, G & Østergren, P B 2019, ' Fatigue, quality of life and metabolic changes in men treated with first-line enzalutamide versus abiraterone plus prednisolone for metastatic castration-resistant prostate cancer (HEAT) : A randomised trial protocol ', BMJ Open, vol. 9, no. 9, e030218 . https://doi.org/10.1136/bmjopen-2019-030218
Ternov, K K, Sønksen, J, Fode, M, Lindberg, H, Kistorp, C M, Bisbjerg, R, Palapattu, G & Østergren, P B 2019, ' Fatigue, quality of life and metabolic changes in men treated with first-line enzalutamide versus abiraterone plus prednisolone for metastatic castration-resistant prostate cancer (HEAT) : A randomised trial protocol ', BMJ Open, vol. 9, no. 9, e030218 . https://doi.org/10.1136/bmjopen-2019-030218
IntroductionEnzalutamide and abiraterone acetate plus prednisolone (AAP) are used in combination with androgen-deprivation therapy to further suppress the androgen stimulation of metastatic castration-resistant prostate cancer (mCRPC). First-line mCR
Publikováno v:
Scandinavian journal of urology. 49(2)
The aim of this study was to present the outcome of patients treated with salvage cryotherapy after radiotherapy for prostate cancer at one institution.Consecutive patients treated between 2007 and 2013 with transperineal cryotherapy for biopsy-verif
Publikováno v:
University of Southern Denmark
Ternov, K K, Østergren, P B, Fode, M & Lund, L 2022, ' Erektil dysfunktion og metabolisk syndrom ', Ugeskrift for Laeger, bind 184, nr. 42, V03220227 . < https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-10/v03220227_web.pdf >
Ternov, K K, Østergren, P B, Fode, M & Lund, L 2022, ' Erektil dysfunktion og metabolisk syndrom ', Ugeskrift for Laeger, bind 184, nr. 42, V03220227 . < https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-10/v03220227_web.pdf >
This review covers erectile dysfunction (ED) in men with metabolic syndrome. Men suffering from metabolic syndrome, and all its components, are at increased risk of ED. Men with ED should be metabolically screened with BMI, waist circumference, blood
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f8995abbc241e3aa8612821529a9b021
https://portal.findresearcher.sdu.dk/en/publications/74ebf199-3d50-4c06-8a14-c51b5464c0ab
https://portal.findresearcher.sdu.dk/en/publications/74ebf199-3d50-4c06-8a14-c51b5464c0ab